Command Palette

Search for a command to run...

HSIL

290+0.00%

Market Cap
₹378.11 Cr
Stock P/E
47.02
ROCE
13.58%
ROE
12.73%
Book Value
₹87.71

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Foreign Investors
Domestic Investors
Public

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Hemant Surgical Industries Ltd. shows significant weaknesses in growth, profitability, and valuation metrics compared to its peers in the Medical Equipment/Supplies sector. While its peers demonstrate varying degrees of performance, Poly Medicure Ltd. stands out as a leader in growth and profitability, whereas Nureca Ltd. is flagged as financially weak due to negative earnings and high valuation ratios.

Key Points
  • Poly Medicure Ltd. shows the highest revenue growth and profitability metrics, making it a sector leader.
  • Nureca Ltd. has negative EPS and the highest PE ratio, indicating it is financially risky.
  • Hemant Surgical Industries Ltd. lacks growth and profitability, with no revenue or earnings reported.
Top Performers
Poly Medicure Ltd.

Highest revenue growth (YoY: 21.37%) and strong profitability metrics (ROE: 16.01%).

Prevest Denpro Ltd.

Solid profitability with ROE of 18.70% and attractive valuation metrics.

Laxmi Dental Ltd.

High ROE of 96.95%, despite high PE, indicating strong earnings generation.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.